Host Immunity and Immunization Strategies for Clostridioides difficile Infection
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Host Immunity and Immunization Strategies for Clostridioides difficile Infection
Authors
Keywords
-
Journal
CLINICAL MICROBIOLOGY REVIEWS
Volume 36, Issue 2, Pages -
Publisher
American Society for Microbiology
Online
2023-05-10
DOI
10.1128/cmr.00157-22
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection of Newly Secreted Antibodies Predicts Non-recurrence in Primary Clostridioides difficile Infection
- (2022) Natalie S. Haddad et al. JOURNAL OF CLINICAL MICROBIOLOGY
- SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection
- (2022) Paul Feuerstadt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Binary Toxin Expression by Clostridioides difficile Is Associated With Worse Disease
- (2022) Mary K Young et al. Open Forum Infectious Diseases
- TFPI is a colonic crypt receptor for TcdB from hypervirulent clade 2 C. difficile
- (2022) Jianhua Luo et al. CELL
- Towards Development of a Non-Toxigenic Clostridioides difficile Oral Spore Vaccine against Toxigenic C. difficile
- (2022) Jaime Hughes et al. Pharmaceutics
- Development of an Effective Nontoxigenic Clostridioides difficile–Based Oral Vaccine against C. difficile Infection
- (2022) Shaohui Wang et al. Microbiology Spectrum
- Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota
- (2021) Joshua R. Fletcher et al. Nature Communications
- Host immunity modulates the efficacy of microbiota transplantation for treatment of Clostridioides difficile infection
- (2021) Eric R. Littmann et al. Nature Communications
- Functional analyses of epidemic Clostridioides difficile toxin B variants reveal their divergence in utilizing receptors and inducing pathology
- (2021) Zhenrui Pan et al. PLoS Pathogens
- C. difficile exploits a host metabolite produced during toxin-mediated disease
- (2021) Kali M. Pruss et al. NATURE
- Large Clostridial Toxins: Mechanisms and Roles in Disease
- (2021) Kathleen E. Orrell et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota
- (2020) Hiroko Nagao-Kitamoto et al. NATURE MEDICINE
- Considering the Immune System during Fecal Microbiota Transplantation for Clostridioides difficile Infection
- (2020) Alyse L. Frisbee et al. TRENDS IN MOLECULAR MEDICINE
- Clostridium difficile Infection: An Epidemiology Update
- (2020) Ana C. De Roo et al. Clinics in Colon and Rectal Surgery
- The Inflammasome and Type-2 Immunity in Clostridium difficile Infection
- (2020) Alexandra Donlan et al. Clinics in Colon and Rectal Surgery
- Diarrhoeal events can trigger long-term Clostridium difficile colonization with recurrent blooms
- (2020) David VanInsberghe et al. Nature Microbiology
- Enabling anti-tumor immunity by unleashing ILC2
- (2020) Irene Mattiola et al. CELL RESEARCH
- Interaction between microbiota and immunity in health and disease
- (2020) Danping Zheng et al. CELL RESEARCH
- SER-109, an Investigational Microbiome Drug to Reduce Recurrence after Clostridioides difficile infection: Lessons Learned from a Phase 2 Trial
- (2020) Barbara H McGovern et al. CLINICAL INFECTIOUS DISEASES
- IL-17–producing γδ T cells protect against Clostridium difficile infection
- (2020) Yee-Shiuan Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes
- (2020) Alice Y. Guh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Plasminogen Exacerbates Clostridioides difficile Enteric Disease and Alters the Spore Surface
- (2020) M.M. Awad et al. GASTROENTEROLOGY
- Human C. difficile toxin-specific memory B cell repertoires encode poorly-neutralizing antibodies
- (2020) Hemangi B. Shah et al. JCI Insight
- Subtyping analysis reveals new variants and accelerated evolution of Clostridioides difficile toxin B
- (2020) Enhui Shen et al. Communications Biology
- Gold Nanoclusters as an Antibacterial Alternative Against Clostridium difficile
- (2020) Huan Yang et al. International Journal of Nanomedicine
- The adaptive immune response to Clostridioides difficile : A tricky balance between immunoprotection and immunopathogenesis
- (2020) Rodrigo Emanuel Hernández Del Pino et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial
- (2020) Guy de Bruyn et al. LANCET INFECTIOUS DISEASES
- Reuterin disrupts Clostridioides difficile metabolism and pathogenicity through reactive oxygen species generation
- (2020) Melinda A. Engevik et al. Gut Microbes
- Type 2 cytokines IL-4 and IL-5 reduce severe outcomes from Clostridiodes difficile infection
- (2020) Alexandra N. Donlan et al. ANAEROBE
- Recurrent Clostridioides difficile Infection Is Associated With Impaired T Helper Type 17 Immunity to C difficile Toxin B
- (2020) Laura Cook et al. GASTROENTEROLOGY
- Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection — An observational cohort study
- (2020) Sylvia Polivkova et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- New insights for vaccine development against Clostridium difficile infections
- (2019) Marjorie Pizarro-Guajardo et al. ANAEROBE
- Colitis-Induced Th17 Cells Increase the Risk for Severe Subsequent Clostridium difficile Infection
- (2019) Mahmoud M. Saleh et al. Cell Host & Microbe
- IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection
- (2019) Alyse L. Frisbee et al. Nature Communications
- Innate Lymphoid Cells in the Induction of Obesity
- (2019) Takaharu Sasaki et al. Cell Reports
- “The recent emergence of a highly related virulent Clostridium difficile clade with unique characteristics”
- (2019) Helen Alexandra Shaw et al. CLINICAL MICROBIOLOGY AND INFECTION
- The interaction of intestinal microbiota and innate lymphoid cells in health and disease throughout life
- (2019) Stephanie C. Ganal‐Vonarburg et al. IMMUNOLOGY
- Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
- (2019) Zachariah DeFilipp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity and Protection from Receptor-Binding Domains of Toxins as Potential Vaccine Candidates for Clostridium difficile
- (2019) Deyan Luo et al. Vaccines
- Characterization of the Immune Response during Infection Caused by Clostridioides difficile
- (2019) Hamo et al. Microorganisms
- Clostridioides difficile Infection Induces an Inferior IgG Response to That Induced by Immunization and Is Associated with a Lack of T Follicular Helper Cell and Memory B Cell Expansion
- (2019) Souwelimatou Amadou Amani et al. INFECTION AND IMMUNITY
- Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2
- (2019) José Luís Fachi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Therapeutic Mechanism of Macrophage Inflammatory Protein 1 α Neutralizing Antibody (CCL3) in Clostridium difficile Infection in Mice
- (2019) Jiani Wang et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
- (2018) L Clifford McDonald et al. CLINICAL INFECTIOUS DISEASES
- Understanding Clostridium difficile Colonization
- (2018) Monique J. T. Crobach et al. CLINICAL MICROBIOLOGY REVIEWS
- Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota
- (2018) Julie A.K. McDonald et al. GASTROENTEROLOGY
- The ATP-P2X7 Signaling Axis Is an Essential Sentinel for Intracellular Clostridium difficile Pathogen-Induced Inflammasome Activation
- (2018) Ya-Hui Liu et al. Frontiers in Cellular and Infection Microbiology
- Clostridioides difficile Biology: Sporulation, Germination, and Corresponding Therapies for C. difficile Infection
- (2018) Duolong Zhu et al. Frontiers in Cellular and Infection Microbiology
- Nuts and Bolts of Fecal Microbiota Transplantation
- (2018) Edward Krajicek et al. Clinical Gastroenterology and Hepatology
- Safety and efficacy of a minimally invasive cell sampling device (‘Cytosponge’) in the diagnosis of esophageal pathology
- (2018) Umair Iqbal et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridium difficileinfection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
- (2018) Benjamin H Mullish et al. GUT
- Oral immunization with non-toxic C. difficile strains expressing chimeric fragments of TcdA and TcdB elicits protective immunity against C. difficile infection in both mice and hamsters
- (2018) Yuanguo Wang et al. INFECTION AND IMMUNITY
- Diagnosis and Treatment of Clostridium difficile Infection
- (2018) Arjun Gupta et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Development and Validation of a Prediction Model for Mortality and Adverse Outcomes Among Patients With Peripheral Eosinopenia on Admission for Clostridium difficile Infection
- (2018) Audrey S. Kulaylat et al. JAMA Surgery
- A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients
- (2018) Oluwaseun Shogbesan et al. Canadian Journal of Gastroenterology and Hepatology
- Five years of fecal microbiota transplantation - an update of the Israeli experience
- (2018) Sharon A Greenberg et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Apoptosis of intestinal epithelial cells restricts Clostridium difficile infection in a model of pseudomembranous colitis
- (2018) Pedro H. V. Saavedra et al. Nature Communications
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains
- (2017) Susan Secore et al. PLoS One
- Immunization with Recombinant TcdB-Encapsulated Nanocomplex Induces Protection against Clostridium difficile Challenge in a Mouse Model
- (2017) Yi-Wen Liu et al. Frontiers in Microbiology
- Induction of antitoxin responses in Clostridium-difficile-infected patients compared to healthy blood donors
- (2016) Alice von Eichel-Streiber et al. ANAEROBE
- Neutrophil-mediated inflammation in the pathogenesis of Clostridium difficile infections
- (2016) Shinsmon Jose et al. ANAEROBE
- Immunogenic properties of the surface layer precursor of Clostridium difficile and vaccination assays in animal models
- (2016) J.-F. Bruxelle et al. ANAEROBE
- Interaction of gut microbiota with bile acid metabolism and its influence on disease states
- (2016) Christopher Staley et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile
- (2016) Bao-Zhong Zhang et al. BMC INFECTIOUS DISEASES
- Antibodies to Toxin B Are Protective AgainstClostridium difficileInfection Recurrence
- (2016) Swati B. Gupta et al. CLINICAL INFECTIOUS DISEASES
- Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa
- (2016) B. Kullin et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Analysis of TcdB Proteins within the Hypervirulent Clade 2 Reveals an Impact of RhoA Glucosylation on Clostridium difficile Proinflammatory Activities
- (2016) Carlos Quesada-Gómez et al. INFECTION AND IMMUNITY
- Coordination between T helper cells, iNKT cells, and their follicular helper subsets in the humoral immune response against Clostridium difficile toxin B
- (2016) Pragya Rampuria et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers
- (2016) Nicole Bézay et al. VACCINE
- Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial
- (2016) Guy de Bruyn et al. VACCINE
- Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection
- (2016) Erica L. Buonomo et al. Cell Reports
- Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects
- (2016) Stefano Di Bella et al. Toxins
- Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC
- (2016) Chandrabali Ghose et al. Emerging Microbes & Infections
- Clostridium difficile infection
- (2016) Wiep Klaas Smits et al. Nature Reviews Disease Primers
- The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia
- (2016) Carrie A. Cowardin et al. Nature Microbiology
- Multi-functional nano silver: A novel disruptive and theranostic agent for pathogenic organisms in real-time
- (2016) Ponnusamy Manogaran Gopinath et al. Scientific Reports
- Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection
- (2015) Michael C. Abt et al. Cell Host & Microbe
- Fatal Aspiration Pneumonia as a Complication of Fecal Microbiota Transplant
- (2015) M. Baxter et al. CLINICAL INFECTIOUS DISEASES
- Diversity and Evolution in the Genome of Clostridium difficile
- (2015) Daniel R. Knight et al. CLINICAL MICROBIOLOGY REVIEWS
- Memory B Cells Encode Neutralizing Antibody Specific for Toxin B from the Clostridium difficile Strains VPI 10463 and NAP1/BI/027 but with Superior Neutralization of VPI 10463 Toxin B
- (2015) T. Scott Devera et al. INFECTION AND IMMUNITY
- Outcomes of Clostridium difficile Infection in Hospitalized Leukemia Patients: A Nationwide Analysis
- (2015) Ruihong Luo et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- The Prospect for Vaccines to Prevent Clostridium difficile Infection
- (2015) Chandrabali Ghose et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Administration of Spores of NontoxigenicClostridium difficileStrain M3 for Prevention of RecurrentC difficileInfection
- (2015) Dale N. Gerding et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Exposure of Neutralizing Epitopes in the Carboxyl-terminal Domain of TcdB Is Altered by a Proximal Hypervariable Region
- (2015) Jason L. Larabee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genomic Epidemiology of a Protracted Hospital Outbreak Caused by a Toxin A-Negative Clostridium difficile Sublineage PCR Ribotype 017 Strain in London, England
- (2015) M. D. Cairns et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Clostridium difficile Infection
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Burden of Clostridium difficile Infection in the United States
- (2015) Fernanda C. Lessa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammasome Activation Contributes to Interleukin-23 Production in Response to Clostridium difficile
- (2015) Carrie A. Cowardin et al. mBio
- Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections
- (2015) Glen P. Carter et al. mBio
- Clostridium difficile: New Insights into the Evolution of the Pathogenicity Locus
- (2015) Marc Monot et al. Scientific Reports
- Tempered Enthusiasm for Fecal Transplant
- (2014) P. R. Solari et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials
- (2014) Stuart Johnson et al. CLINICAL INFECTIOUS DISEASES
- Humoral immune response as predictor of recurrence in Clostridium difficile infection
- (2014) M.P. Bauer et al. CLINICAL MICROBIOLOGY AND INFECTION
- Immunomodulatory properties of the vaccine adjuvant alum
- (2014) Ewa Oleszycka et al. CURRENT OPINION IN IMMUNOLOGY
- Plasma cell numbers decrease in bone marrow of old patients
- (2014) Theresa Pritz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- MHC-II: A Mutual Support System for ILCs and T Cells?
- (2014) Rick M. Maizels et al. IMMUNITY
- Group 2 Innate Lymphoid Cells Are Critical for the Initiation of Adaptive T Helper 2 Cell-Mediated Allergic Lung Inflammation
- (2014) Timotheus Y.F. Halim et al. IMMUNITY
- MHCII-Mediated Dialog between Group 2 Innate Lymphoid Cells and CD4+ T Cells Potentiates Type 2 Immunity and Promotes Parasitic Helminth Expulsion
- (2014) Christopher J. Oliphant et al. IMMUNITY
- Interleukin-22 Regulates the Complement System to Promote Resistance against Pathobionts after Pathogen-Induced Intestinal Damage
- (2014) Mizuho Hasegawa et al. IMMUNITY
- Oral, Capsulized, Frozen Fecal Microbiota Transplantation for RelapsingClostridium difficileInfection
- (2014) Ilan Youngster et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens
- (2014) Theresa L. Geiger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Clostridium difficile recurrence is characterized by pro-inflammatory peripheral blood mononuclear cell (PBMC) phenotype
- (2014) M. B. Yacyshyn et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Synthetic Polymers Active against Clostridium difficile Vegetative Cell Growth and Spore Outgrowth
- (2014) Runhui Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome
- (2014) Hao Xu et al. NATURE
- Activated group 3 innate lymphoid cells promote T-cell-mediated immune responses
- (2014) N. von Burg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Risk factors for recurrentClostridium difficileinfection in hematopoietic stem cell transplant recipients
- (2014) A.M. Huang et al. Transplant Infectious Disease
- Vaccines against Clostridium difficile
- (2014) Rosanna Leuzzi et al. Human Vaccines & Immunotherapeutics
- Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis
- (2013) Zain Kassam et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Meta-Analysis of Antibiotics and the Risk of Community-Associated Clostridium difficile Infection
- (2013) Kevin A. Brown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Transient Flare of Ulcerative Colitis After Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
- (2013) Lauren M. De Leon et al. Clinical Gastroenterology and Hepatology
- Editorial Commentary: Does Infection With Specific Clostridium difficile Strains or Clades Influence Clinical Outcome?
- (2013) D. N. Gerding et al. CLINICAL INFECTIOUS DISEASES
- Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile Infection
- (2013) A. Sarah Walker et al. CLINICAL INFECTIOUS DISEASES
- European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection
- (2013) S.B. Debast et al. CLINICAL MICROBIOLOGY AND INFECTION
- Diagnosis of Clostridium difficile Infection: an Ongoing Conundrum for Clinicians and for Clinical Laboratories
- (2013) C.-A. D. Burnham et al. CLINICAL MICROBIOLOGY REVIEWS
- Clostridium difficile infection in children hospitalized due to diarrhea
- (2013) K. Dulęba et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Protection from Clostridium difficile Infection in CD4 T Cell- and Polymeric Immunoglobulin Receptor-Deficient Mice
- (2013) Pehga F. Johnston et al. INFECTION AND IMMUNITY
- Identification of a novel type 2 innate immunocyte with the ability to enhance IgE production
- (2013) Ayumi Fukuoka et al. INTERNATIONAL IMMUNOLOGY
- Functional Characterization of Clostridium difficile Spore Coat Proteins
- (2013) P. Permpoonpattana et al. JOURNAL OF BACTERIOLOGY
- Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection
- (2013) Rodrigo Quera et al. Journal of Crohns & Colitis
- Role of Interleukin 23 Signaling in Clostridium difficile Colitis
- (2013) Erica L. Buonomo et al. JOURNAL OF INFECTIOUS DISEASES
- Importance of Toxin A, Toxin B, and CDT in Virulence of an Epidemic Clostridium difficile Strain
- (2013) Sarah A. Kuehne et al. JOURNAL OF INFECTIOUS DISEASES
- A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile
- (2013) R. G. K. Donald et al. MICROBIOLOGY-SGM
- Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria
- (2013) Matthew R. Hepworth et al. NATURE
- TH2, allergy and group 2 innate lymphoid cells
- (2013) Paula Licona-Limón et al. NATURE IMMUNOLOGY
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating Antibody and Memory B-Cell Responses to C. difficile Toxins A and B in Patients with C. difficile-Associated Diarrhoea, Inflammatory Bowel Disease and Cystic Fibrosis
- (2013) Tanya M. Monaghan et al. PLoS One
- Clostridium difficile toxin B-induced necrosis is mediated by the host epithelial cell NADPH oxidase complex
- (2013) M. A. Farrow et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of Clostridium difficile Toxin A and B on Human T Lymphocyte Migration
- (2013) Dan Wu et al. Toxins
- Difference in F-Actin Depolymerization Induced by Toxin B from the Clostridium difficile Strain VPI 10463 and Toxin B from the Variant Clostridium difficile Serotype F Strain 1470
- (2013) Martin May et al. Toxins
- Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin
- (2012) I. Figueroa et al. CLINICAL INFECTIOUS DISEASES
- Current Status of Clostridium difficile Infection Epidemiology
- (2012) F. C. Lessa et al. CLINICAL INFECTIOUS DISEASES
- Faecal microbiota transplantation for severe clostridium difficile infection in the intensive care unit
- (2012) Jason A. Trubiano et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Innate Lymphoid Cell Interactions with Microbiota: Implications for Intestinal Health and Disease
- (2012) Gregory F. Sonnenberg et al. IMMUNITY
- A Chimeric Toxin Vaccine Protects against Primary and Recurrent Clostridium difficile Infection
- (2012) Haiying Wang et al. INFECTION AND IMMUNITY
- Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection
- (2012) P.N. Wiegand et al. JOURNAL OF HOSPITAL INFECTION
- Clostridium difficile Spore-Macrophage Interactions: Spore Survival
- (2012) Daniel Paredes-Sabja et al. PLoS One
- Follicular Helper CD4 T Cells (TFH)
- (2011) Shane Crotty Annual Review of Immunology
- Host S-nitrosylation inhibits clostridial small molecule–activated glucosylating toxins
- (2011) Tor C Savidge et al. NATURE MEDICINE
- Host and Pathogen Factors forClostridium difficileInfection and Colonization
- (2011) Vivian G. Loo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fidaxomicin versus Vancomycin forClostridium difficileInfection
- (2011) Thomas J. Louie et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Changing Epidemiology of Clostridium difficile Infections
- (2010) J. Freeman et al. CLINICAL MICROBIOLOGY REVIEWS
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
- (2010) Daniel R. Neill et al. NATURE
- The role of toxin A and toxin B in Clostridium difficile infection
- (2010) Sarah A. Kuehne et al. NATURE
- Treatment with Monoclonal Antibodies againstClostridium difficileToxins
- (2010) Israel Lowy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon
- (2010) M. C. Rea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulatory T Cells Reinforce Intestinal Homeostasis
- (2009) Michael J. Barnes et al. IMMUNITY
- Toxin B is essential for virulence of Clostridium difficile
- (2009) Dena Lyras et al. NATURE
- Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
- (2009) Kazuyo Moro et al. NATURE
- Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)
- (2009) Brett A. Leav et al. VACCINE
- Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection
- (2008) S. Dial et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Clostridium difficile cell-surface polysaccharides composed of pentaglycosyl and hexaglycosyl phosphate repeating units
- (2008) Jeyabarathy Ganeshapillai et al. CARBOHYDRATE RESEARCH
- Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences
- (2008) R. A. Stabler et al. JOURNAL OF MEDICAL MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now